ACA
SBIO icon

Aptus Capital Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Aptus Capital Advisors’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6K Hold
180
– – ﹤0.01% 1585
2026
Q1 		$9.42K Hold
180
– – ﹤0.01% 1498
2025
Q4 		$9.22K Buy
+180
New +$8.32K ﹤0.01% 1503

Other funds holding SBIO

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CIS
Connors Investor Services Wyomissing, Pennsylvania $1.16B AUM 27.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MWM
Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Aptus Capital Advisors's SBIO Position: Q2 2026 in Review

Aptus Capital Advisors held its ALPS Medical Breakthroughs ETF (SBIO) position steady in Q2 2026 at 180 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1585.

Aptus Capital Advisors first reported a position in SBIO in Q4 2025 and has held it in 3 quarters since. 66 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • Aptus Capital Advisors held 180 shares of ALPS Medical Breakthroughs ETF worth $11.6K as of Q2 2026.
  • Aptus Capital Advisors left its ALPS Medical Breakthroughs ETF share count unchanged in Q2 2026.
  • ALPS Medical Breakthroughs ETF made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #1585 holding.
  • Aptus Capital Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q4 2025 and has held it in 3 quarters since.
  • 66 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.